Compass Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
1,233
+7
+0.6% +$1.55K 0.12% 47
2025
Q4
$280K Buy
1,226
+7
+0.6% +$1.59K 0.12% 40
2025
Q3
$282K Buy
1,219
+9
+0.7% +$1.83K 0.12% 41
2025
Q2
$225K Buy
1,210
+75
+7% +$13.9K 0.11% 45
2025
Q1
$238K Buy
1,135
+41
+4% +$7.97K 0.12% 39
2024
Q4
$194K Buy
+1,094
New +$201K 0.11% 39

Other funds holding ABBV

Compass Financial Services's ABBV Position: Q1 2026 in Review

Compass Financial Services increased its AbbVie (ABBV) stake by 0.57% in Q1 2026, buying an estimated $1.55K and bringing the position to 1,233 shares worth $268K. The position accounts for 0.12% of the portfolio, ranked #47.

Compass Financial Services first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $282K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Compass Financial Services held 1,233 shares of AbbVie worth $268K as of Q1 2026.
  • Compass Financial Services bought 7 AbbVie shares in Q1 2026, an estimated $1.55K.
  • AbbVie made up 0.12% of Compass Financial Services's portfolio in Q1 2026, its #47 holding.
  • Compass Financial Services first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Compass Financial Services's AbbVie position peaked at $282K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Compass Financial Services's 13F filing for Q1 2026, filed 1 May 2026.